Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification
Nicholas J. Izzo, Carla M. Yuede, Kelsie M. LaBarbera, Colleen S. Limegrover, Courtney Rehak, Raymond Yurko, Lora Waybright, Gary Look, Gilbert Rishton, Hank Safferstein, Mary E. Hamby, Claire Williams, Kelsey Sadlek, Hannah M. Edwards, Charles S. Davis, Michael Grundman, Lon S. Schneider, Steven T. DeKosky, Daniel Chelsky, Ian PikeChristopher Henstridge, Kaj Blennow, Henrik Zetterberg, Harry LeVine, Tara L. Spires-Jones, John R. Cirrito, Susan M. Catalano
Research output: Contribution to journal › Article › peer-review
59Scopus
citations
Fingerprint
Dive into the research topics of 'Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification'. Together they form a unique fingerprint.